Calls for global guidelines for safer AI use in medicine
A world-first review led by Adelaide University researchers has found there’s a lack of clear guidelines around the early testing of AI tools in health clinics, during a… read more.
A world-first review led by Adelaide University researchers has found there’s a lack of clear guidelines around the early testing of AI tools in health clinics, during a… read more.
Novocure announced that the FDA approved Optune Pax, Tumor Treating Fields (TTFields) device for the treatment of adult patients with locally advanced pancreatic cancer concomitant with gemcitabine and… read more.
You don’t need to look like a bodybuilder, but for healthy aging, maintaining muscle strength is likely just as important as getting enough aerobic activity. That’s according to… read more.
Intermittent fasting is unlikely to lead to greater weight loss in overweight or obese adults than traditional dietary advice or doing nothing, a new Cochrane review finds. Obesity… read more.
Citius Oncology Inc., the oncology-focused subsidiary of Citius Pharmaceuticals Inc. announced that it has entered into an exclusive distribution agreement with Uniphar , a leading international healthcare services… read more.
Reduce, reuse, recycle, and rethink can be applied in Canadian operating rooms (ORs) to increase environmental sustainability, advises a new guideline published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251192. As the… read more.
Deaths due to synthetic opioids nitazenes have likely been underestimated by up to a third. King’s College London research, published today in Clinical Toxicology, sheds light on the… read more.
KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting FRAMINGHAM, Mass. & SALISBURY, England–(BUSINESS WIRE)–Feb. 12, 2026– KalVista Pharmaceuticals, Inc…. read more.
PTC Therapeutics Inc. announced that it has withdrawn the New Drug Application (NDA) resubmission for Translarna (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (DMD) following… read more.
American women now have the option of screening for cervical cancer at home, using newly approved self-collection tools. While experts hope this will increase uptake in the under-screened population, a… read more.
More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS… read more.
Key data from Merck’s portfolio and pipeline to be presented at the 2026 ASCO GU Cancers Symposium: First-time data from the Phase 3 KEYNOTE-B15/EV-304 trial evaluating KEYTRUDA, Merck’s… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.